DK0937259T3 - Fremgangsmåde til ekstraktion af proteiner - Google Patents

Fremgangsmåde til ekstraktion af proteiner

Info

Publication number
DK0937259T3
DK0937259T3 DK97910561T DK97910561T DK0937259T3 DK 0937259 T3 DK0937259 T3 DK 0937259T3 DK 97910561 T DK97910561 T DK 97910561T DK 97910561 T DK97910561 T DK 97910561T DK 0937259 T3 DK0937259 T3 DK 0937259T3
Authority
DK
Denmark
Prior art keywords
proteins
extracting proteins
extraction
disaggregating
homogenised
Prior art date
Application number
DK97910561T
Other languages
Danish (da)
English (en)
Inventor
Jostein Holtund
Siri Dale
Magne K Fagerhol
Original Assignee
Magne K Fagerhol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26310325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0937259(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9622839A external-priority patent/GB9622839D0/en
Priority claimed from GB9707148A external-priority patent/GB9707148D0/en
Application filed by Magne K Fagerhol filed Critical Magne K Fagerhol
Application granted granted Critical
Publication of DK0937259T3 publication Critical patent/DK0937259T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805Haemoglobins; Myoglobins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/813Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Extraction Or Liquid Replacement (AREA)
DK97910561T 1996-11-01 1997-11-03 Fremgangsmåde til ekstraktion af proteiner DK0937259T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9622839A GB9622839D0 (en) 1996-11-01 1996-11-01 Process
GB9707148A GB9707148D0 (en) 1997-04-08 1997-04-08 Process
EP97910561A EP0937259B1 (de) 1996-11-01 1997-11-03 Verfahren zur proteinextraktion

Publications (1)

Publication Number Publication Date
DK0937259T3 true DK0937259T3 (da) 2005-01-31

Family

ID=26310325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97910561T DK0937259T3 (da) 1996-11-01 1997-11-03 Fremgangsmåde til ekstraktion af proteiner

Country Status (12)

Country Link
US (1) US6225072B1 (de)
EP (1) EP0937259B1 (de)
JP (1) JP4105768B2 (de)
AT (1) ATE278964T1 (de)
AU (1) AU4790597A (de)
CA (1) CA2268926A1 (de)
DE (1) DE69731103T2 (de)
DK (1) DK0937259T3 (de)
ES (1) ES2225956T3 (de)
NO (1) NO326302B1 (de)
PT (1) PT937259E (de)
WO (1) WO1998020355A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229747D0 (en) 2002-12-20 2003-01-29 Axis Shield Asa Assay
JP5227418B2 (ja) * 2007-11-20 2013-07-03 エフ.ホフマン−ラ ロシュ アーゲー マーカー組み合わせカルプロテクチンおよびヘモグロビン/ハプトグロビン複合体の使用による便試料からの結腸直腸癌の評価方法
WO2010062663A1 (en) * 2008-11-03 2010-06-03 Schering Corporation Inflammatory bowel disease biomarkers and related methods of treatment
EP2202320A1 (de) 2008-12-24 2010-06-30 Agendia B.V. Verfahren und Mittel zur Typisierung einer Probe mit Kolorektalkrebszellen
US20130164776A1 (en) 2009-11-23 2013-06-27 Lars Olof A Hansson Method used in a human or animal faeces sample processing system, and a sample processing system
NO20110895A1 (no) 2011-06-21 2012-12-24 Magne Fagerhol Kompetitive S100A9 immunoanalyser
NO336551B1 (no) 2011-06-21 2015-09-28 Magne Fagerhol Forbedret ELISA for kalprotektin i fekalprøve eller gastrointestinaltraktsprøve
WO2013132347A2 (en) 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
WO2013132338A2 (en) 2012-03-06 2013-09-12 Calpro As Competitive immunoassay for calprotectin
EP2947459B1 (de) 2014-05-21 2017-07-12 Bühlmann Laboratories AG Verfahren zur Bestimmung eines Proteins
WO2017049035A1 (en) 2015-09-17 2017-03-23 Amgen Inc. Prediction of clinical response to il23-antagonists using il23 pathway biomarkers
AU2016379157A1 (en) 2015-12-22 2018-06-21 Amgen Inc. CCL20 as a predictor of clinical response to IL23-antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8318754D0 (en) 1983-07-11 1983-08-10 Fagerhol M K F Human proteins anti-sera test kits
EP0281251A3 (de) * 1987-02-04 1988-09-28 International Immunoassay Laboratories, Inc. Verfahren zur Zubereitung einer fäkalen Probenzusammensetzung für immunologische Nachprüfung
US5139934A (en) * 1990-05-25 1992-08-18 Becton, Dickinson And Company Substrate composition and method for solid phase urease immunoassay
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system

Also Published As

Publication number Publication date
US6225072B1 (en) 2001-05-01
PT937259E (pt) 2005-01-31
JP4105768B2 (ja) 2008-06-25
NO992099D0 (no) 1999-04-30
EP0937259B1 (de) 2004-10-06
ES2225956T3 (es) 2005-03-16
WO1998020355A1 (en) 1998-05-14
AU4790597A (en) 1998-05-29
DE69731103D1 (de) 2004-11-11
EP0937259A1 (de) 1999-08-25
DE69731103T2 (de) 2005-11-17
JP2001503863A (ja) 2001-03-21
NO992099L (no) 1999-04-30
NO326302B1 (no) 2008-11-03
ATE278964T1 (de) 2004-10-15
CA2268926A1 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
DK0937259T3 (da) Fremgangsmåde til ekstraktion af proteiner
WO1999042839A3 (en) Treating cancer
DE69533159D1 (de) Miniaturisierte probenvorbereitungsvorrichtungen sowie systeme zur feststellung und behandlung von analyten
CA2143999A1 (en) Device and method for combined bioaffinity assay and electrophoretic separation
GB9709728D0 (en) Single step method
HK1008442A1 (en) Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
WO1998009170A3 (en) Methods and compositions for the detection of cervical cancer
AU5794498A (en) Releasable nonvolatile mass-label molecules
WO2000020846A8 (en) Method for imaging tissue
EA200001073A1 (ru) Устройство и способ для отбора и первичной подготовки проб ткани для молекулярной генной диагностики
DE69731504D1 (de) Reagenz und Verfahren zur Freisetzung und Bestimmung von Blei in biologischen Matrices
EP0803577A3 (de) Verfahren zur Detektion und/oder Bestimmung von ATP aus Mikroorganismcellen in einer Probe
CA2133560A1 (en) Hair analysis method
WO2001055708A3 (en) Method of processing a sample containing at least one biological element
WO2001057537A3 (en) Methods for diagnosis of alzheimer's disease
NO20021787D0 (no) Fremgangsmåte for bestemmelse av stoffer ved hjelp av evaneschensfeltfremgangsmåten
CA2383554A1 (en) Methods for the detection, analysis and isolation of nascent proteins
WO2001079541A8 (en) Improvements in and relating to analysis of dna samples
WO2004063714A3 (en) Methods for the detection, analysis and isolation of nascent proteins
WO1995035492A3 (de) Verfahren und vorrichtung zur gezielten entnahme von komponenten aus komplexen mischungen
IL117201A0 (en) Process for quantitative detection of analytes and ferrimagnetic and ferromagnetic compounds for use therein
EP0990901A3 (de) Computergestützte Identifizierung von Paraproteinen
AU1421902A (en) Gel trap for electrophoresis
WO2001049872A3 (en) Diagnostic analytical method and kit
AU1314997A (en) Analytical apparatus